Literature DB >> 17071638

Endocrine signaling in ovarian surface epithelium and cancer.

Peter C K Leung1, Jung-Hye Choi.   

Abstract

Ovarian cancer is the sixth most common cancer and the fifth leading cause of cancer-related death among women in developed countries. Greater than 85% of human ovarian cancer arises within the ovarian surface epithelium (OSE), with the remainder derived from granulosa cells or, rarely, stroma or germ cells. The pathophysiology of ovarian cancer is the least understood among all major human malignancies because of a poor understanding of the aetiological factors and mechanisms of ovarian cancer progression. There is increasing evidence suggesting that several key reproductive hormones, such as GnRH, gonadotrophins and sex steroids, regulate the growth of normal OSE and ovarian cancer cells. The objective of this review was to highlight the effects of these endocrine factors on ovarian cancer cell growth and to summarize the signalling mechanisms involved in normal human OSE and its neoplastic counterparts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071638     DOI: 10.1093/humupd/dml002

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  34 in total

Review 1.  Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer.

Authors:  Shelley B Hooks; Mandi M Murph
Journal:  Future Med Chem       Date:  2015-08-21       Impact factor: 3.808

2.  Hormonal risk factors for ovarian cancer in the Albanian case-control study.

Authors:  Edlira Pajenga; Tefta Rexha; Silva Çeliku; Gazmend Bejtja; Mimoza Pisha
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

3.  Ovarian surface epithelium receptors during pregnancy and estrus cycle of rats with emphasis on steroids and gonadotropin fluctuation.

Authors:  Salina Y Saddick
Journal:  Saudi J Biol Sci       Date:  2014-03-13       Impact factor: 4.219

4.  New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research.

Authors:  Mark E Sherman; Richard Guido; Nicolas Wentzensen; Hannah P Yang; Phuong L Mai; Mark H Greene
Journal:  Gynecol Oncol       Date:  2012-08-29       Impact factor: 5.482

Review 5.  The luteinizing hormone receptor: insights into structure-function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells.

Authors:  David Puett; Krassimira Angelova; Marcelo Rocha da Costa; Susanne W Warrenfeltz; Francesca Fanelli
Journal:  Mol Cell Endocrinol       Date:  2010-05-02       Impact factor: 4.102

6.  Douching, Talc Use, and Risk of Ovarian Cancer.

Authors:  Nicole L Gonzalez; Katie M O'Brien; Aimee A D'Aloisio; Dale P Sandler; Clarice R Weinberg
Journal:  Epidemiology       Date:  2016-11       Impact factor: 4.822

7.  Blocking epidermal growth factor receptor activation by 3,3'-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo.

Authors:  Prabodh K Kandala; Stephen E Wright; Sanjay K Srivastava
Journal:  J Pharmacol Exp Ther       Date:  2011-12-28       Impact factor: 4.030

8.  Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.

Authors:  Nathan J Charles; Peter Thomas; Carol A Lange
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

9.  The role of activin A and Akt/GSK signaling in ovarian tumor biology.

Authors:  Thuy-Vy Do; Lena A Kubba; Monica Antenos; Alfred W Rademaker; Charles D Sturgis; Teresa K Woodruff
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

10.  Estrous cycle modulates ovarian carcinoma growth.

Authors:  Guillermo N Armaiz-Pena; Lingegowda S Mangala; Whitney A Spannuth; Yvonne G Lin; Nicholas B Jennings; Alpa M Nick; Robert R Langley; Rosemarie Schmandt; Susan K Lutgendorf; Steven W Cole; Anil K Sood
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.